Lv1
58 积分 2024-09-14 加入
Advancements and challenges in CAR T cell therapy in autoimmune diseases
13天前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
13天前
已完结
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia
25天前
已完结
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
29天前
已关闭
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging
29天前
已完结
Diagnosis and Treatment of Myelodysplastic Syndromes: A Review
30天前
已完结
CircRNA-based, non-integrated, in vivo panCAR-mediated B cell immune resetting in mouse models and non-human primates
1个月前
已完结
CDK inhibitors from past to present: A new wave of cancer therapy
1个月前
已完结
Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia
1个月前
已完结
AML treatment: conventional chemotherapy and emerging novel agents
1个月前
已完结
皖公网安备34019202002308
